Patents by Inventor Sebastian PEIL

Sebastian PEIL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR C-H INSERTION BY GEM-HYDROGENATION OF AN INTERNAL ALKYNE
    Publication number: 20250059200
    Abstract: The present invention is directed to a process for C—H insertion by the gem-hydrogenation of an internal alkyne.
    Type: Application
    Filed: November 29, 2022
    Publication date: February 20, 2025
    Applicant: Studiengesellschaft Kohle gGmbH
    Inventors: Alois FUERSTNER, Sebastian PEIL
  • Cis-8-(3,5-difluorophenyl)-8-(dimethylamino)-1,3-diazaspiro[4.5]decan-2-one derivatives
    Publication number: 20240400537
    Abstract: The invention relates to cis-8-(3,5-difluorophenyl)-8-(dimethylamino)-1,3-diazaspiro[4.5]-decan-2-one derivatives, their preparation and use in medicine, particularly in various neurological disorders, including but not limited to pain, neurodegenerative disorders, neuroinflammatory disorders, neuropsychiatric disorders, substance abuse/dependence.
    Type: Application
    Filed: April 24, 2024
    Publication date: December 5, 2024
    Applicant: Gruenenthal GmbH
    Inventors: Sebastian PEIL, Inna SLYNKO, Philipp BARBIE, Nikolay SITNIKOV, Ingo KONETZKI, Mauro MARIGO, David ST. JEAN, Martin PETTERSSON
  • Substituted pyrazole amides
    Patent number: 11999699
    Abstract: The present invention relates to compounds according to general formula (I) which act as inhibitors of NaV1.8 and can be used in the treatment of pain.
    Type: Grant
    Filed: June 15, 2022
    Date of Patent: June 4, 2024
    Assignee: GRÜNENTHAL GMBH
    Inventors: Sebastian Krueger, Sebastian Peil, Clemens Dialer, Marcel Muelbaier, Markus Wagener, Ingo Konetzki, Nikolay Sitnikov, Jo Alen, Martin Pettersson
  • SUBSTITUTED PYRAZOLE AMIDES
    Publication number: 20230025025
    Abstract: The present invention relates to compounds according to general formula (I) which act as inhibitors of NaV1.8 and can be used in the treatment of pain.
    Type: Application
    Filed: June 15, 2022
    Publication date: January 26, 2023
    Applicant: GRUENENTHAL GMBH
    Inventors: Sebastian KRUEGER, Sebastian PEIL, Clemens DIALER, Marcel MUELBAIER, Markus WAGENER, Ingo KONETZKI, Nikolay SITNIKOV, Jo ALEN, Martin PETTERSSON